Gerald has maintained that an RS (if necessary) and subsequent uplist will be from a position of strength. If we are still at .15 in November, I don't see an RS/uplist occurring, unless that strategy has changed.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
